Effect of Non-alcoholic Fatty Liver Disease on Kidney Functions
NCT ID: NCT03172650
Last Updated: 2017-08-16
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
120 participants
OBSERVATIONAL
2017-07-01
2018-09-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Kidney Affection in Non Alcaholic Fatty Liver Diseases
NCT04273230
Pattern and Short Term Outcomes of Renal Affection in Patients With Liver Cirrhosis in Al-Rajhi Liver Hospital
NCT06924294
Acute Liver Injury in Patients With Pneumonia
NCT06103981
Evaluation of Hepatic Affection in Hemodialysis Patients With Iron Overload in Assiut University Hospital
NCT05028595
Correlation Between Serum Albumin Level and Severity of Hepatic Encephalopathy in Patients With Chronic Liver Disease in Sohag University Hospital
NCT06953921
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_CONTROL
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
study group
non alcoholic fatty liver disease patients
glomerular filtration rate
collection of blood sample 5 milliliter for calculation of glomerular filtration rate
Control group
fatty liver patients
glomerular filtration rate
collection of blood sample 5 milliliter for calculation of glomerular filtration rate
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
glomerular filtration rate
collection of blood sample 5 milliliter for calculation of glomerular filtration rate
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Urine analysis whether normal or renal sedimentation.
Exclusion Criteria
2. patients known to have diabetes mellitus.
3. patients with other causes of liver disease as viral hepatitis, drug induced,or autoimmune.
4. patients known to have kidney disease.
5. Hypertension.
6. Hyperuricemia.
7. Impaired urea and creatinine patients.
18 Years
70 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Assiut University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Ahmed Mohamed Abbas
principal investigator
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Ahmed Abbas
Assiut, Cairo Governorate, Egypt
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
ahmed abbas
Role: backup
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
NAFLD
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.